AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 74 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 6.67 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $70,000 | – | 6,448 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLP GROUP LLC | 2,904,185 | $43,563,000 | 46.00% |
| Foresite Capital Management II, LLC | 3,967,900 | $59,519,000 | 28.42% |
| Aisling Capital LLC | 2,990,000 | $44,850,000 | 9.24% |
| Foresite Capital Management III, LLC | 935,020 | $14,025,000 | 6.56% |
| Vivo Capital, LLC | 763,009 | $11,445,000 | 3.57% |
| RA Capital Management | 1,292,940 | $19,394,000 | 2.00% |
| Palo Alto Investors LP | 379,727 | $5,696,000 | 0.33% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 418,214 | $6,273,000 | 0.32% |
| EMERALD ADVISERS, LLC | 464,364 | $6,965,000 | 0.31% |
| Rock Springs Capital Management LP | 293,000 | $4,395,000 | 0.28% |